Neurodevelopmental Outcomes in Children with Exposure to Prescription Stimulants During Pregnancy
Prenatal exposure to prescription stimulants was not associated with an increased risk of neurodevelopmental disorders in exposed children.
Prenatal exposure to prescription stimulants was not associated with an increased risk of neurodevelopmental disorders in exposed children.
Vigilance is required in screening women who present with postpartum depression; a subset of women who screen positive for depression may actually have bipolar disorder.
There are many different sources of information, some better than others.
More study is needed regarding the safety of trazodone for the treatment of insomnia during pregnancy.
Compared to individuals with histories of psychiatric illness prior to pregnancy, perinatal individuals without a prepregnancy psychiatric history were less likely to be screened, referred, and treated for depression.
Psychological interventions may reduce the severity of perinatal anxiety symptoms.
Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in [...]
Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.
ADHD is an important risk factor for both depression and anxiety disorders in the postpartum period and should be considered in the post-pregnancy maternal care.
There is evidence that screening for perinatal mood and anxiety disorders may improve outcomes; however, success depends on adequate resources for screening, diagnosis, treatment and follow-up.